We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Microscope Offers Unprecedented Deep and Wide-Field Visualization of Brain Activity at Single-Cell Resolution

By LabMedica International staff writers
Posted on 18 Nov 2024

Conventional multiphoton microscopy, which is fundamental for deep-tissue imaging, faces significant challenges related to imaging depth and field of view, particularly in highly scattering biological tissues such as the brain. More...

To enhance imaging depth while preventing thermal damage, the field of view often diminishes exponentially, complicating the observation of extensive neuronal networks. Now, a groundbreaking microscope has been developed to overcome these limitations by incorporating a range of innovative techniques, enabling researchers to visualize vast areas of the brain at unmatched depths.

A research team at Cornell University (Ithaca, NY, USA) has introduced an advanced imaging technology that offers exceptional deep and wide-field visualization of brain activity at single-cell resolution. This microscope, known as DEEPscope, merges two-photon and three-photon microscopy techniques to capture expansive neural activity and structural details that were previously difficult to access. A key aspect of this advancement is DEEPscope’s adaptive excitation system along with its multi-focus polygon scanning scheme, which facilitates efficient fluorescence generation for large field-of-view imaging. These features enable high-resolution imaging over a 3.23 x 3.23-mm² area with sufficient speed to record neuronal activity in the deepest layers of mouse cortical tissue. Additionally, the capacity for simultaneous two-photon and three-photon imaging increases the system's versatility, enabling detailed investigations of both superficial and deeper brain regions.

In a study published in the journal eLight, the researchers demonstrated DEEPscope’s ability to image entire cortical columns and subcortical structures with single-cell resolution. They successfully recorded neuronal activity in deep brain regions of transgenic mice, observing more than 4,500 neurons across both shallow and deep cortical layers. Furthermore, DEEPscope facilitated whole-brain imaging in adult zebrafish, capturing structural details at depths exceeding 1 mm and across a field greater than 3 mm—an achievement unprecedented in neuroscience. The techniques demonstrated can be seamlessly integrated into existing multiphoton microscopes, making them accessible for broad applications in neuroscience and other disciplines that require deep-tissue imaging. By addressing previous constraints, DEEPscope establishes a new benchmark for large-field, high-resolution, deep imaging of living tissues, with the potential to enhance understanding of the brain’s complex networks and their significance in health and disease.

“DEEPscope represents a significant advancement in brain imaging technology,” said Aaron Mok, the study's lead author. “For the first time, we can visualize complex neural circuits in living animals at such a large scale and depth, providing insights into brain function and potentially opening new avenues for neurological research.”


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
HPV Test
Allplex HPV28 Detection
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers combined a blood-based biomarker of Alzheimer’s disease with age, sex, and genetic risk to estimate future cognitive impairment risk in asymptomatic adults (Image Credit: Adobe Stock)

Blood Biomarker Model May Help Estimate Five- and 10-Year Cognitive Impairment Risk

Estimating future cognitive impairment risk remains challenging in cognitively healthy adults, particularly when biomarker findings are reduced to simple positive or negative results. Because mild cognitive... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Lung Cancer Atlas Reveals Cellular Patterns Associated With Patient Prognosis

Lung cancer is a leading cause of cancer-related death worldwide and is characterized by substantial cellular heterogeneity. Even within a single tumor, cancer cells can vary in aggressiveness, while immune,... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.